When marketing trumps medicine: MedCity Morning Read, Feb. 15, 2010
The runaway popularity of robotic prostate surgery is a case study in the triumph of marketing over medicine, and for that reason, it could be a glimpse into the future.
Don’t blame immigrants for high U.S. health costs: MedCity Morning Read, Feb. 12, 2010
While some lawmakers delight in blaming immigrants for contributing to rapidly rising U.S. health costs, that conclusion is off base, according to a study in Health Affairs. The authors write, "Health care expenditures for the average immigrant have not been a growing problem relative to expenditures among U.S. natives."
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Cleveland Clinic gets grants, license agreement, invests in digital medicine — MedCity Evening Read, Dec. 8, 2009
The Cleveland Clinic has received a $2.75 million federal grant to study the use of stem cells in treating multiple sclerosis, received a grant of more than $123,000 from NFL Charities to explore treatments for shoulder instability, licensed a system to replace damaged or severed mitral valve chordae in the heart and invested $100 million in digital record-keeping.
Should drugstore chains own pharmacy benefits managers? MedCity (afternoon) read, May 13, 2009
When drugstore chain CVS said in 2006 that it would buy CareMark Rx -- one of the nation's largest pharmacy benefits managers -- critics complained that the combination could create a conflict of interests. Could the conflict be here?